The following grants were approved by Komen’s national board of directors for FY2011 Research Programs funding, and will be funded once the grant agreements between Komen and the grantee institutions are fully-executed. There are 5 types (mechanisms) of grants: Career Catalyst Research (CCR), Investigator Initiated Research (IIR), Post Baccalaureate Training in Disparities Research (PBTDR), Postdoctoral Fellowship (PDF), and Promise Grants (PG).

Select a column title to sort this information.
Select a Project Title for detailed grant information.
Download Printable Version

Type to Search:
Project Title Investigators Organization State/ Country Affiliate Mechanism Awarded Total
A Multi-Gene Assay for the Prognostic Stratification of Ductal Carcinoma in situ Joseph Geradts, M.D.Duke University NCNC Triangle AffiliateIIR $599,998
A Novel Protein that Controls Homologous Recombination in Breast Cancer  Alan D'Andrea, M.D. (mentor);
George-Lucian Moldovan, Ph.D. (fellow)
Dana-Farber Cancer InstituteMAMassachusetts AffiliatePDFBR$180,000
A Novel Rac-GEF in Breast Cancer  Marcelo Kazanietz, Ph.D. (mentor);
Eva Wertheimer, Ph.D. (fellow)
University of Pennsylvania PAPhiladelphia Affiliate PDFBR$180,000
A Novel Strategy to Target Breast Cancer Stem cells Utilizing microRNA100 Suling Liu, Ph.D.University of Michigan MIMid-Michigan AffiliateCCR $450,000
A Transdisciplinary Training Program for Public Health Master and Doctoral Students Wanting to Impact Breast Cancer Disparities  Luisa Franzini, Ph.D.;
Sally Vernon, Ph.D.
University of Texas at Houston TXHouston AffiliatePBTDR$269,722
Analysis of the Mechanisms that Mediate Cell-cell Adhesion Strengthening and its Importance in Breast Cancer Invasion  Joan Brugge, Ph.D. (mentor);
Lisa Gallegos, Ph.D. (fellow)
Harvard University MAMassachusetts AffiliatePBTDR$180,000
Angiogenesis-Independent Tumor Penetrating Peptides for Breast Cancer Drug Delivery Tambet Teesalu, Ph.D.Burnham Institute CA None CCR $450,000
Blood Based Biomarkers of High Risk and Early Breast Cancer  Samir Hanash, M.D., Ph.D.;
Mary Disis, M.D.
Fred Hutchinson Cancer Research Center University of Washington WAPuget Sound AffiliateIIR$599,999
Characterization of the Role of Galectins in Mammary Gland Morphogenesis and in Breast Cancer  Mina Bissell, Ph.D. (mentor);
Ramray Bhat, Ph.D. (fellow)
Lawrence Berkeley National Laboratory CASan Francisco Bay Area AffiliatePDFBR$177,988
Circulating Folic Acid, DHFR Polymorphism, Multivitamin Use, and Breast Cancer Risk  Anne Zeleniuch-Jacquotte, M.D. (mentor);
Stephanie Scarmo, Ph.D. (fellow)
New York University NYGreater New York City AffiliatePDFTR$120,000
Combinatorial Immunotherapy for Triple-negative Breast Cancer  Soldano Ferrone, M.D., Ph.D. (mentor);
Yangyang Wang, M.D. (fellow)
University of Pittsburgh PAPittsburgh AffiliatePDFTR$180,000
Crosstalk among MED1, ER and HER2: New Strategy to Overcome Endocrine Resistance in Breast Cancer Xiaoting Zhang, Ph.D.University of Cincinnati OHGreater Cincinnati AffiliateCCR$450,000
Determining the Molecular Effects of Bisphenol A (BPA) in Mammary Gland Stem Cells and Breast Cancer Proliferation Susan Krum, Ph.D.University of California at Los AngelesCALos Angeles County AffiliateCCR$450,000
Development of First-generation Multiplex Metabolomic Biomarker Panel in Serum for Diagnosis and Prognosis of Breast Cancer  Arun Sreekumar, Ph.D. Baylor College of Medicine TX Houston Affiliate IIR$600,000
Development of Novel Therapeutics for the Treatment of Triple-negative Breast Cancer using Targeted Nanoparticle-mediated Delivery of siRNA to Solid Tumors  Frank McCormick, Ph.D. (mentor);
Tina Yuan, Ph.D. (fellow)
University of California at San Francisco CA San Francisco Bay Area AffiliatePDFBR$180,000
Development of Synthetic Antigen Binders against Nek3 as a Targeted Therapy in Breast Cancer  Charles Clevenger, M.D., Ph.D. (mentor);
Christine Ratajczak, Ph.D. (fellow)
Northwestern University IL Chicagoland Area AffiliatePDFTR$180,000
Development of Targeted “Smart” Particles for Silencing the Metastases of Breast Cancer  Mohamed El-Sayed, Ph.D. (mentor);
Sofia Merajver, M.D., Ph.D. (mentor);
Yasemin Yuksel Durmaz, Ph.D. (fellow)
University of Michigan MI Mid-Michigan AffiliatePDFTR$180,000
Disparities in Breast Cancer Outcomes: The Role of Comorbid Conditions and Functional Status  Dejana Braithwaite, Ph.D.University of California at San Francisco CA San Francisco Bay Area Affiliate CCR $284,273
Enhancing Efficacy of Chemotherapy in Triple-negative/Basal-like Breast Cancer by Targeting Macrophages 

Lisa Coussens, Ph.D.;
Shelley Hwang, M.D.;
Hope Rugo, M.D.

University of California at San Francisco CA San Francisco Bay Area Affiliate PG $6,500,000
Epigenetic Control of Metastases by the Snail/Slug Transcription Factors Frank Rauscher, Ph.D. Wistar Institute PA Philadelphia Affiliate IIR $599,999
Evaluating the Role of Anthrax Toxin Receptor 2 in the Myoepithelium During Breast Cancer Progression Jan Kitajewski, Ph.D. (mentor);
Claire Reeves, Ph.D. (fellow)
Columbia University NY Greater New York City Affiliate PDFBR $180,000
Evaluation and Development of Breast Cancer Risk Prediction Models among African-American Women Lynn Rosenberg, ScD (mentor);
Deborah Boggs, ScD (fellow)
Boston University MA Massachusetts Affiliate PDFDR $178,191
Evaluation of Genetic Risk in Caribbean Women with Breast and Ovarian Cancer Judith Hurley, M.D. University of Miami FL Miami/Ft. Lauderdale Affiliate IIR $599,997
Evaluation of Novel Serum Biomarkers for Hispanic Women with Breast Cancer Nita Maihle, Ph.D. Yale University CT Connecticut Affiliate PBTDR $270,000
Examining the Role of COX-2 in Initiation and Progression of Post-partum Breast Cancer Pepper Schedin, Ph.D. (mentor);
Virginia Borges, M.D. (mentor);
Traci Lyons, Ph.D. (fellow)
University of Colorado CO Denver Metropolitan Affiliate PDFBR $120,000
Functional Study of UBLCP1, A Novel Proteasome-interacting Phosphatase, in Breast Cancer Jack Dixon, Ph.D. (mentor);
Xing Guo, Ph.D. (fellow)
University of California at San Diego CA San Diego Affiliate PDFBR $180,000
Germline Mutations in Genes that Modify Epigenetic Silencing in Familial Breast Cancer Georgia Chenevix-Trench, Ph.D.;
Kum Kum Khanna, Ph.D.
Queensland Institute of Medical Research Australia none IIR $585,265
Gli1 in the Development and Persistence of Micrometastases of Breast Cancer Andra Frost, M.D. University of Alabama at Birmingham AL North Central Alabama Affiliate IIR $600,000
Hedgehog Signaling in Breast Cancer: Tumor-stroma Interactions and the Growth of Tumor-Initiating Cells Philip Beachy, Ph.D. (mentor);
Michael Clarke, M.D. (mentor);
Chen Zhao, Ph.D. (fellow)
Stanford University CA San Francisco Bay Area Affiliate PDFTR $180,000
HIF-1 and Extracellular Matrix Composition in Breast Cancer Gregg Semenza, M.D., Ph.D. (mentor);
Daniele Gilkes, Ph.D. (fellow)
Johns Hopkins University M.D. Maryland Affiliate PDFBR $180,000
Identification of Key Tumor Suppressor Genes in the Breast Cancer Genome as Biomarkers of Response to Chemotherapy or Prognosis Jerry Shay, Ph.D. (mentor);
Stina Singel, M.D., Ph.D. (fellow)
University of Texas at Southwestern Medical Center at Dallas TX Dallas County Affiliate PDFCR $180,000
Identification of Lapatinib Resistance Genes in HER2 Positive Breast Cancers using Genome-wide RNAi Technologies Thomas Westbrook, Ph.D. (mentor);
C. Kent Osborne, M.D. (mentor);
Christopher Bland, Ph.D. (fellow)
Baylor College of Medicine TX Houston Affiliate PDFBR $180,000
Imaging Breast Cancer with Tc-99m Labeled Acridines by Targeting Telomere/Telomerase Complex Shuang Liu, Ph.D. (mentor);
Yang Zhou, Ph.D. (fellow)
Purdue University IN Central Indiana Affiliate PDFBR $180,000
Immune and Collagen Basis of Breast Cancer Risk Shelley Hwang, M.D.;
Lisa Coussens, Ph.D.
Duke University NC NC Triangle Affiliate IIR $599,996
Immune Biomarkers of Breast Cancer Risk in Benign Breast Tissue Amy Degnim, M.D. Mayo Clinic and Foundation, Rochester MN Minnesota Affiliate IIR $600,000
Immune-based Suppression of Breast Cancer Metastasis by Targeting IDO Alexander Muller, Ph.D. Lankenau Institute for Medical Research PA Philadelphia Affiliate IIR $599,774
Impact of the miR-26 Family of microRNAs on the Stromal-epithelial Dialogue in Breast Cancer Thomas Duchaine, Ph.D. (mentor);
Morag Park, Ph.D. (mentor);
Carine Lussier, Ph.D. (fellow)
McGill University Canada none PDFBR $180,000
Improving Microcalcification Reconstruction in Digital Tomosynthesis Mammography for Early Detection of Breast Cancer Heang-Ping Chan, Ph.D. (mentor);
Yao Lu, Ph.D. (fellow)
University of Michigan MI Mid-Michigan Affiliate PDFBR $180,000
Inhibiting the Emergence of Endocrine Resistance in Women with Estrogen Receptor-positive Metastatic Breast Cancer Luke Whitesell, M.D.;
Nancy Lin, M.D.
Whitehead Institute for Biomedical Research Dana-Farber Cancer Institute MA Massachusetts Affiliate IIR $600,000
Inhibition of Metastatic Breast Cancer by Angiotensin-(1-7) Elisabeth Tallant, Ph.D.;
Patricia Gallagher, Ph.D.
Wake Forest University NC North Carolina Triad Affiliate IIR $600,000
Molecular Marker Signature Prognostic of Metastatic Disease in Node-negative ER-negative Breast Cancer with no Systemic Therapy Christopher Umbricht, M.D., Ph.D. Johns Hopkins University M.D. Maryland Affiliate IIR $599,353
Molecular Mechanisms of Snail-induced Epithelial-mesenchymal Transition Alexey Ivanov, Ph.D. West Virginia University WV West Virginia Affiliate CCR $450,000
Multilevel Determinants of Breast Density in African-American, Hispanic, and White Women Parisa Tehranifar, DrPH Columbia University NY Greater New York City Affiliate CCR $448,742
New Strategies for Monitoring Response to Breast Cancer Therapy using Photoacoustic Molecular Imaging Sanjiv Gambhir, M.D., Ph.D. (mentor);
Dominique Van de Sompel, Ph.D. (fellow)
Stanford University CA San Francisco Bay Area Affiliate PDFTR $180,000
New Tools for Studying the Biology of BRCA1 Eric Strieter, Ph.D. University of Wisconsin at Madison WI Madison Affiliate CCR $447,705
Novel Estrogen Receptor Modulators to Treat Endocrine Therapy Resistant Hormone Receptor Positive Breast Cancers Rajeshwar Tekmal, Ph.D.;
Ratna Vadlamudi, Ph.D.
University of Texas Health Science Center at San Antonio TX San Antonio Affiliate IIR $600,000
Personalized Breast Cancer Vaccines Based on Genome Sequencing William Gillanders, M.D.;
Ted Hansen, Ph.D.;
Elaine Mardis, Ph.D.
Washington University at St. Louis MO St. Louis Affiliate PG $6,500,000
PI3K/Akt Isoforms and PTEN Signaling in Breast Cancer Invasive Migration Alex Toker, Ph.D. (mentor);
Emilie Collmann, Ph.D. (fellow)
Beth Israel Deaconess Medical Center MA Massachusetts Affiliate PDFBR $180,000
Preclinical Development of a PEA-15-Based Therapy for Triple-Negative Breast Cancer Chandra Bartholomeusz, M.D., Ph.D. (mentor);
Xuemei Xie, Ph.D. (fellow)
University of Texas M.D. Anderson Cancer Center TX Houston Affiliate PDFTR $180,000
Predicting Response to Neoadjuvant Chemotherapy using Optical Tomographic Imaging in Women with Breast Cancer Dawn Hershman, M.D. (mentor);
Emerson Lim, M.D. (fellow)
Columbia University NY Greater New York City Affiliate PDFCR $120,000
Predictors and Mechanisms of Relapse after Aromatase Inhibitor Therapy: Targeting IL-6 and STAT3 Angela DeMichele, M.D. University of Pennsylvania PA Philadelphia Affiliate IIR $600,000
Progesterone Receptor Interactions with Cell Cycle Regulatory Molecules Promote Breast Tumor Initiation and Progression. Carol Lange, Ph.D. (mentor);
Gwen Dressing, Ph.D. (fellow)
University of Minnesota at Twin Cities MN Minnesota Affiliate PDFBR $180,000
Promoting Regular Screening Mammography in an American Indian Community in Oklahoma Eleni Tolma, Ph.D. University of Oklahoma OK Central and Western Oklahoma Affiliate IIR $599,966
Racial Disparities in Cardiovascular Morbidity and Mortality Resulting from Aromatase Inhibitors among African-American and Caucasian Breast Cancer Survivors Lisa Gallicchio, Ph.D. Mercy Medical Center M.D. Maryland Affiliate CCR $448,610
Regulation of Breast Cancer Metastasis by the K63-specific Ubiquitin-conjugating Enzyme Ubc13 Michael Karin, Ph.D. (mentor);
Xuefeng Wu, Ph.D. (fellow)
University of California at San Diego CA San Diego Affiliate PDFBR $180,000
Role of SCF/Fbxo31 Ubiquitin Ligase Substrates in Cell Cycle Control and Breast Cancer Michele Pagano, M.D. (mentor);
Shanshan Duan, Ph.D. (fellow)
New York University NY Greater New York City Affiliate PDFBR $180,000
Role of Tumor Cell-derived ShcA in Regulating the Adaptive Immune Response during Breast Cancer Progression Josie Ursini-Siegel, Ph.D. Jewish General Hospital Canada none CCR $449,982
Role of Wnt Signaling and Pygo2 in the Epigenetic Control of Normal and Cancerous Mammary Epithelial Cells Xing Dai, Ph.D. University of California at Irvine CA Orange County Affiliate IIR $600,000
Strategic Global Mining of Methylated Promoter Sites in a Diverse ER-negative Primary Care Breast Cancer Population Maria Worsham, Ph.D. Henry Ford Health System MI Komen Detroit Race for the Cure® IIR $599,850
Structural Models of Breast Cancer Outcomes Disparities Terry Hyslop, Ph.D. Thomas Jefferson University PA Philadelphia Affiliate IIR $600,000
Targeting VCAM1 to Prevent Metastatic Recurrence from Dormant Bone Micrometastases Yibin Kang, Ph.D. Princeton University NJ Central and South Jersey Affiliate IIR $588,750
Technology Enhanced Nurse Navigation (TENN): Improving Care, Saving Lives Kathy Helzlsouer, M.D. Mercy Medical Center M.D. Maryland Affiliate IIR $599,883
Testing the Role of Non-canonical FAK Signaling in Breast Cancer Metastasis David Schlaepfer, Ph.D. (mentor);
Isabelle Tanjoni, DVM, Ph.D. (fellow)
University of California at San Diego CA San Diego Affiliate PDFBR $180,000
The Assessment of the HOXB13:IL17BR+MGI Breast Cancer Biomarker in the BIG 1-98 Cohort Dennis Sgroi, M.D. Massachusetts General Hospital MA Massachusetts Affiliate IIR $400,000
The Effect of a Dietary Supplement Silibinin on Breast Cancer Tumor Initiating Cells in Inflammatory Breast Cancer Wendy Woodward, M.D., Ph.D. (mentor);
Wei Xu, Ph.D. (fellow)
UT M.D. Anderson Cancer Center TX Houston Affiliate PDFTR $120,000
The Massively Parallel Sequencing of Epigenetic Pathway in High-risk Breast Cancer Families Tomas Kirchhoff, Ph.D. New York University NY Greater New York City Affiliate IIR $600,000
The Molecular Basis of Breast Density and its Implications for Breast Cancer Prevention Kornelia Polyak, M.D., Ph.D.;
Rulla Tamimi, Sc.D.
Dana-Farber Cancer Institute Brigham and Women's Hospital MA Massachusetts Affiliate IIR $600,000
The Role of Cytotoxic Tumor Entrained Neutrophils in Inhibiting Metastatic Breast Cancer Robert Benezra, Ph.D. (mentor);
Elizabeth Comen, M.D. (fellow)
Memorial Sloan-Kettering Cancer Center NY Greater New York City Affiliate PDFCR $120,000
The Warburg Effect Revisited: Does Increased Glucose Uptake in Mammary Cells from African-American Women Predict Aggressive Triple-Negative Breast Cancer? Victoria Seewaldt, M.D. (mentor);
Nirmala Ramanujam, Ph.D. (mentor);
Abigail Hoffman, M.D. (fellow)
Duke University NC NC Triangle Affiliate PDFCR $180,000
Toward Novel Drugs for Anti-Estrogen Resistant Breast Cancer Eliot Rosen, M.D., Ph.D. Georgetown University DC Global Race for the Cure® IIR $600,000
Treatment of Her-2 Overexpressing Breast Cancer with Targeted Immunoliposomes Thomas Anchordoquy, Ph.D. (mentor);
Max Kullberg, Ph.D. (fellow)
University of Colorado at Denver CO Denver Metropolitan Affiliate PDFTR $180,000
Tumor Macrophage-mediated Inflammatory Resolution Limits Endogenous Immune Control of Residual Disease Michael Gough, Ph.D. Providence Portland Medical Center OR Oregon and SW Washington Affiliate CCR $449,887
Tumor-derived Jagged1 Promotes Breast Cancer Bone Metastasis by Activating Stromal Notch Signaling Yibin Kang, Ph.D. (mentor);
Hanqiu Zheng, Ph.D. (fellow)
Princeton University NJ Central and South Jersey Affiliate PDFBR $180,000
Twist1 and Breast Cancer Micrometastases Dormancy Gregory Longmore, M.D. Washington University at St. Louis MO St. Louis Affiliate IIR $600,000
UIC Komen Cancer Epidemiology and Health Disparities Fellowship Garth Rauscher, Ph.D.;
Faith Davis, Ph.D.
University of Illinois at Chicago University of Illinois at Chicago School of Public Health IL Chicagoland Area Affiliate PBTDR $403,119
Vaccine Strategy to Treat and Prevent Resistance to Anti-estrogen Therapy in Breast Cancer Takuya Osada, M.D., Ph.D. Duke University NC NC Triangle Affiliate CCR $380,048
The Role of Endothelial MicroRNA-126 in Breast Tumor Progression and Angiogenesis

Calvin Kuo, M.D., Ph.D. (mentor);
Cynthia Kosinski, Ph.D. (fellow)

Standford University CA San Francisco Bay Area Affiliate PDFBR $180,000
A Novel Combination Therapy for Triple Negative Breast Cancer: Erlotinib And Metformin Matthew Maurer, M.D. Columbia University NY Greater New York City Affiliate CCR $450,000
Development of an individualized risk prediction model for women with atypical hyperplasia Derek Radisky, Ph.D.;
Lynn Hartmann, M.D.
Mayo Clinic and Foundation
Mayo Clinic and Foundation
FL
MN
North Florida Affiliate
Minnesota Affiliate
IIR $597,939
Development of Pin1 inhibitors to treat aggressive and/or drug-resistant breast cancers Kun Ping Lu, M.D., Ph.D. (mentor);
Shuo Wei, Ph.D. (fellow)
Beth Israel Deaconess Medical Center MA Massachusetts Affiliate PDFTR $180,000
Ecdysoneless, a novel regulator of breast cancer cell proliferation Vimla Band, Ph.D. (mentor);
Sameer Mirza, Ph.D. (fellow)
University of Nebraska NE Nebraska Affiliate PDFBR $180,000
FACBC PET as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients Gary Ulaner, M.D., Ph.D. Memorial Sloan-Kettering Cancer Center NY Greater New York City Affiliate CCR $300,000
Genomic signatures to guide breast cancer analysis and personalize therapy Eran Andrechek, Ph.D. Michigan State University MI Mid-Michigan Affiliate CCR $450,000
GREB1: A Novel Prognostic and Therapeutic Target in Breast Cancers with Resistance to Endocrine Therapies Marc Lippman, M.D.;
H. James Hnatyszyn, Ph.D.
University of Miami FL Miami/Ft. Lauderdale Affiliate IIR $600,000
Identifying the Missing Heritability of Breast Cancer. Melissa Southey, Ph.D. (mentor);
Tu Nguyen-Dumont, Ph.D. (fellow)
University of Melbourne Australia none PDFBR $180,000
Investigating the signaling pathways involved in the ECM degradation by breast cancer cells. John Condeelis, Ph.D. (mentor);
Ved Sharma, Ph.D. (fellow)
Albert Einstein College of Medicine at Yeshiva University NY Greater New York City Affiliate PDFBR $180,000
Mechanisms of cell migration and invasion in aggressive breast cancer Morag Park, Ph.D. (mentor);
Kossay Zaoui, Ph.D. (fellow)
McGill University Canada none PDFBR $180,000
Rational Molecular Multi-targeting in High-risk Breast Cancer Kevin Kozak, M.D., Ph.D. University of Wisconsin WI Madison Affiliate CCR $450,000
Role of lymph node lymphangiogenesis and VEGF-C in the progression of micrometastases Mihaela Skobe, Ph.D. Mount Sinai School of Medicine NY Greater New York City Affiliate IIR $600,000
Specific detection of metastases of breast cancer and imaging response to IGF-1R drugs by MRI Deepali Sachdev, Ph.D. University of Minnesota at Twin Cities MN Minnesota Affiliate IIR $599,975
Targeted Therapies for Breast Cancer E. Premkumar Reddy, Ph.D. (mentor);
Sai Krishna Athuluri Divakar, Ph.D. (fellow)
Mount Sinai School of Medicine NY Greater New York City Affiliate PDFTR $180,000
Targeted therapy for micrometastatic minimal residual disease to prevent breast cancer recurrence Lewis Chodosh, M.D., Ph.D. University of Pennsylvania PA Philadelphia Affiliate IIR $600,000
Targeting breast cancer stem cells by blocking both intrinsic (Akt) and extrinsic (IL-6) signaling pathways in metastatic mouse xenograft models Hasan Korkaya, DVM, Ph.D. University of Michigan MI Mid-Michigan Affiliate CCR $450,000
Targeting stem and myoepithelial cells with nutritional compounds to prevent breast cancer in women with high risk ductal carcinoma in situ Madhuri Kakarala, M.D., Ph.D. University of Michigan MI Mid-Michigan Affiliate CCR $450,000
The Breast Cancer Microenvironment Promotes Angiogenesis through Inhibition of TGF-beta Signaling in Endothelial Cells Gerard Blobe, M.D., Ph.D. (mentor);
Hongyu Tian, Ph.D. (fellow)
Duke University NC NC Triangle Affiliate PDFBR $180,000
The Role of Separase in Centrosome Duplication and Genome Stability Tim Stearns, Ph.D. (mentor);
Erkang Ai, Ph.D. (fellow)
Stanford University CA San Francisco Bay Area Affiliate PDFBR $178,225
The role of SLIT/ROBO signaling in generation of breast cancer stem cells Lindsay Hinck, Ph.D. (mentor);
Gwyndolen Harburg, Ph.D. (fellow)
University of California at Santa Cruz CA none PDFBR $180,000
The Use of 2ME2 as a Novel and Effective Therapy for the Treatment of Endocrine Resistant Breast Cancer Growth, Metastasis and Tumor-induced Bone Osteolysis Muzaffer Cicek, Ph.D. Mayo Clinic and Foundation MN Minnesota Affiliate CCR $450,000
Tumor-selectively replicating retrovirus vectors for gene therapy of breast cancer CNS metastasis Noriyuki Kasahara, M.D., Ph.D. (mentor);
Akihito Inagaki, Ph.D. (fellow)
University of California at Los Angeles CA Los Angeles County Affiliate PDFTR $180,000